Surgical Oncology

Axis 1: Treatment of malignant peritoneal disease (MPD)

L1: Natural history of MPD and palliative treatment

L2: Imaging study of MPD (funded study)

L3. Pharmacokinetics of peritoneally administered drugs and delivery of systemic drugs to the peritoneum

Axis 2: Treatment of MPD for cure: cytoreduction + hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC)

L1: Morbidity and mortality of the procedure

L2: Overall and disease-free survival in different tumour types

Axis 3: Treatment of gastric cancer with carcinomatosis using preoperative bidirectional chemotherapy and cytoreduction + HIPEC

L1: Morbidity and mortality of the procedure

L2: Overall and disease-free survival